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ABSTRACT 
Background 
“Brief Limited Intermittent Psychotic Symptoms” (BLIPS) are key inclusion criteria 
to define subjects at ultra high risk for psychosis (UHR). Their diagnostic and 
prognostic significance is unclear. 
Objectives 
To address the baseline diagnostic relationship between BLIPS and the ICD-10 
categories and examine the longitudinal prognostic impact of clinical and 
sociodemographic factors. 
Methods 
Prospective long-term study in UHR subjects meeting BLIPS. Sociodemographic and 
clinical data, including ICD-10 diagnoses, were automatically drawn from electronic 
health records and analyzed using Kaplan-Meier failure function (1-survival), Cox 
regression models, bootstrapping methods and ROC. 
Results 
Eighty BLIPS were included. At baseline, two-thirds (68%) of BLIPS met the criteria 
for ICD-10 “Acute and Transient Psychotic Disorder” (ATPD), most featuring 
schizophrenic symptoms. The remaining subjects had unspecified nonorganic 
psychosis (15%), mental and behavioural disorders due to use of cannabinoids (11%), 
and mania with psychotic symptoms (6%). The overall 5-year risk of psychosis was 
0.54. Recurrent episodes of BLIPS were relatively rare (11%) but associated with a 
higher risk of psychosis (HR 3.98) than mono-episodic BLIPS at the univariate 
analysis. Multivariate analysis revealed that seriously disorganizing or dangerous 
features increased greatly (HR=4.39) the risk of psychosis (0.89 at 5-year). 
Bootstrapping confirmed the robustness of this predictor (area under the ROC = 0.74). 
Conclusions 
BLIPS are most likely to fulfill the ATPD criteria, mainly acute schizophrenic 
subtypes. Recurrent BLIPS are relatively rare but tend to develop into psychosis. 
BLIPS with seriously disorganizing or dangerous features have an extreme high risk 
of psychosis.  
 
INTRODUCTION 
Brief Limited Intermittent Psychotic Symptoms (BLIPS), are one of the three 
operational definitions for subjects at Ultra High Risk for psychosis (hereafter UHR1), 
which were incorporated into the Comprehensive Assessment of At Risk Mental State 
(CAARMS)2, along with Attenuated Psychosis Symptoms (APS) and Genetic Risk 
and Deterioration Syndrome (GRD). BLIPS identify a group of “young people with a 
history of fleeting psychotic experiences that spontaneously resolved within one 
week” (page 8 3), without the use of antipsychotic. Under the UHR paradigm, BLIPS 
are not considered psychotic and do not receive a diagnosis of full-blown psychosis. 
This makes the psychosis threshold of the UHR paradigm different from that of 
current psychiatric classifications such as ICD and DSM4.  
 
However, the actual diagnostic significance of the BLIPS subgroup is unknown. 
Although it has been recommended that BLIPS should be contrasted against 
operationally-based ICD/DSM psychotic disorders (page 706 5), no comparative 
studies have yet been conducted, and hence their relationship deserve clarification. 
The prognostic significance of BLPS is also unclear. A first recent meta-analysis from 
our group has compared the risk of psychosis onset across different UHR subgroups, 
indicating that the BLIPS have a distinct profile, with higher risk of psychosis than 
the APS and GRD subgroups6. Another meta-analysis from our group compared the 
BLIPS against standard ICD-10 and DSM-5 categories of brief psychotic episodes. 
BLIPS were found to have the same risk of psychotic recurrence as the ICD-10 
category of “Acute and transient psychotic disorder” (ATPD) and DSM-5 “Brief 
psychotic disorder” 7, while they have a lower risk than remitted cases of first-episode 
schizophrenia7. However, this meta-analysis did not test whether the diagnoses 
overlapped at baseline or if the same patient could actually be diagnosed with both 
competing constructs. Furthermore, the exact longitudinal course of the BLIPS is still 
not completely clear. Little is known about clinical and socio-demographic factors 
predicting BLIPS outcome. This is probably because case identification is difficult 
owing to the fleeting features and the small number of BLIPS, which account only for 
about 10% of UHR samples6.  For example, although BLIPS cases are by definition 
“intermittent”, the actual proportion and the longitudinal course of recurrent vs mono-
episodic BLIPS is unknown. More to the point, the Structured Interview for 
Prodromal Symptoms (SIPS) and its companion Scale of Prodromal Symptoms 
(SOPS)8, that also address UHR symptoms, have introduced a close variant of the 
BLIPS i.e. “Brief Intermittent Psychotic Symptoms” (BIPS). The SIPS considers 
“seriously disorganizing or dangerous” features as fully psychotic and not as at risk 
BIPS symptoms. Conversely, these features are not routinely assessed with the 
CAARMS and therefore do not constitute exclusion criteria for BLIPS cases (for 
details on the differences between BLIPS and BIPS see Table 1 in9). Yet, the rationale 
for considering seriously disorganizing or dangerous features fully psychotic and 
beyond the UHR state (under the BIPS construct) rather than as UHR symptoms 
(under the BLIPS construct) was not clarified by the SIPS/SOPS authors. Since these 
differences constitute an important source of disagreement between the CAARMS 
and the SIPS10 it is important to explore the actual prognostic significance of seriously 
disorganizing or dangerous features within the BLIPS framework.  
 
We present here the first long-term prospective study in a large sample of BLIPS 
subjects, assessed and treated by a clinical service for UHR subjects11.  The first aim 
of this study is to address the diagnostic significance of the BLIPS, by investigating 
their relationship with competing ICD-10 diagnoses. The second aim of this study is 
to address the prognostic significance of BLIPS by exploring the impact of 
sociodemographic and clinical predictors of psychosis onset.  
 
METHODS 
Sample 
We included all subjects referred for suspicion of psychosis risk to the Outreach and 
Support in South London (OASIS) UHR service, NHS Foundation Trust11, who met 
the BLIPS CAARMS 12/2006 criteria12 up to December 2015. The OASIS team is 
specialized in detecting and treating subjects at UHR for psychosis. It currently covers 
a catchment area of about 1.3 million of individuals in South London (Lambeth, 
Southwark, Lewisham, Croydon), where there is one of the highest rates of psychosis 
in the world and therefore a large proportion of BLIPS among UHR subjects6.  
 
Design 
Prospective long-term study in UHR subjects who met BLIPS criteria.  
 
Clinical assessment 
UHR assessment 
The details of the psychopathological UHR assessment conducted at the OASIS have 
been described previously11. In brief, the UHR assessment is based on the CAARMS 
12/20062. At the end of the assessment the subjects are diagnosed as UHR (APS 
and/or BLIPS and/or GRD), not at risk (UHR-) or already psychotic. Clinical follow-
up is usually performed as part of the standard care. Furthermore, the clinical team 
offers focused interventions spanning pharmacological, psychological and 
psychoeducational activities for two years13. 
 
ICD-10 diagnoses 
The BLIPS is not a codable diagnosis. Therefore, the local NHS Trust requires BLIPS 
subjects to be additionally assigned a psychiatric diagnosis according to ICD-10. The 
diagnostic decision is formulated by psychiatrists working at the OASIS, under the 
supervision of the two consultants who have a long-standing expertise in the 
assessment of UHR cases. 
 
Seriously disorganizing or dangerous 
The notion of seriously disorganizing or dangerous symptom is introduced in the 
SIPS manual with the concept of “urgency” (pages 14-1514). This is defined as 
follows: “urgency is any positive psychotic symptom that is seriously disorganizing or 
dangerous no matter what the duration”14. Further details are provided on page 31 of 
the SIPS manual with the comparative SIPS vs CAARMS table14, and on page 50 of 
the SIPS manual, where the following example can be found: “an example of a 
6 rating on perceptual abnormalities is a patient reporting that he hears the devil 
speaking to him and telling him to hurt himself. He believes the voice is real and he 
believes that he should act on the command. This symptom meets criteria for being 
dangerous as well, and the patient would immediately meet criteria for current 
psychosis”14. Professor Scott Woods provided additional material and a revised 
version of the features, which runs as follows: “’dangerous' is taken to mean 
physically dangerous e.g. risk of death or serious physical injury, and 'disorganizing' 
means potentially psychosocially dangerous, e.g. risk of seriously damaging work 
relations, social relations, family relations, or personal dignity”. As already detailed 
in the introduction, the current study adopted the CAARMS definition of the BLIPS. 
Accordingly, seriously disorganizing and dangerous features have been 
conceptualized as non-psychotic predictors of longitudinal outcomes.  
 
Study measures 
Cross-sectional analysis (diagnostic significance of BLIPS) 
The primary measure was baseline ICD-10 diagnosis of nonorganic psychosis in UHR 
subjects meeting BLIPS (i.e. schizophrenia spectrum psychoses, acute and transient 
psychotic disorders, affective psychoses, substance use psychoses, delusional 
disorders, unspecified nonorganic psychoses, post puerperium psychosis).  
 
Longitudinal analysis (prognostic significance of BLIPS) 
Primary outcome measure for the longitudinal analysis was risk of psychosis over 
time. Predictors of psychosis onset included sociodemographic factors (age, gender, 
borough, ethnicity, marital status, employment status) and clinical factors (Health Of 
the Nation Outcome Scale HoNOS15 total score, baseline SOFAS16, CAARMS P1-
P412 total score, BLIPS duration, BLIPS subgroup, BLIPS recurrence, presence of 
seriously disorganizing or dangerous features). BLIPS recurrence was defined as the 
onset of a second episode of psychosis lasting less than 7 days and not meeting 
psychosis threshold on the CAARMS 12/20062. Psychosis onset was operationalized 
according to the CAARMS 12/20062. 
 
Procedure 
ICD-10 diagnoses of psychosis and other study measures (with the exception of 
seriously disorganizing or dangerous features, see below) were automatically 
extracted by one researcher with the use of the Clinical Record Interactive Search 
(CRIS) tool17 (see eMethods for details on CRIS).  
Seriously disorganizing and dangerous features were selected trough medical records 
screening by two independent psychiatrists who were blind to the outcome of BLIPS, 
under the supervision of a clinician who underwent the SIPS/SOPS training.  
 
Statistical analysis 
Sociodemographic and clinical characteristics of the sample were described with 
mean and SD for continuous variables and absolute and relative frequencies for 
categorical variables. The primary outcome of the cross sectional analysis (diagnostic 
significance of BLIPS as compared with ICD-10) was investigated with absolute and 
relative frequencies tables. The primary outcome of the longitudinal analysis 
(prognostic significance of BLIPS) was investigated with Kaplan Meier18 failure 
function (1-survival)18 and Greenwood 95% CIs19, indicating the risk of transition to 
psychosis during the follow-up. The impact of sociodemographic and clinical factors 
predicting psychosis onset was investigated using Cox proportional hazards models 
evaluating the effects of potential predictors on psychosis onset and time to transition, 
after checking for proportional hazards assumption20. Predictor factors have been 
detailed above here. As previously described21, in the first stage of factors selection, 
all potential factors were computed individually in univariate Cox regression analysis. 
Factors that remained significant at a liberal statistical threshold (p<0.25)22 were 
entered into a multivariate model, built using backward (stepwise, likelihood ratio 
method) inclusion (p<0.05). The -2 log-likelihood ratio test was used to evaluate the 
overall significance of the predictive Cox regression model. The Wald chi-square 
statistic was used to test the significance of individual factors in the model. This 
model was generated using the Akaike information criterion modified for survival 
analyses23. Bootstrap resampling (B=10,000 bootstrap samples) was used to test the 
robustness of the final predictive model24. Apparent model calibration was assessed 
by plotting the Cox predicted curves and comparing them with the Kaplan–Meier 
observed survival curves for the same variable. We further computed Receiver 
Operating Characteristics curve (ROC) to test the apparent discriminative ability of 
the selected model to predict psychosis onset. We used the risk of developing 
psychotic disorders as reference standard and the selected predictor as index test. We 
estimated the summary sensitivity and specificity, positive and negative likelihood 
ratios. We also estimated the Area Under the Curve (AUC)25. The AUC serves as a 
global measure of test performance. Values in the range of 0.9-1 are considered 
outstanding, between 0.8-0.9 excellent, between 0.7-0.8 acceptable26.  
For all the analyses above here, statistical tests were two-sided and statistical 
significance was defined as p values of less than 0.05. All analyses were conducted in 
SPSS, version 22.0 (SPSS, Inc., Chicago) or STATA 13 (STATA Corp., TX, USA). 
 
RESULTS  
Sociodemographic and clinical characteristics of the sample 
As shown in Table 1, 80 subjects with BLIPS (59% males) attended the OASIS 
service until December 2015. Their mean age was 25 years, 72% were single and 
40% unemployed. Proportion of white (48%) and black (45%) ethnicities was similar. 
Most subjects with BLIPS (61%) did not meet other UHR subgroups criteria. About 
one third (27%) had seriously disorganizing or dangerous features according to 
SIPS/SOPS. BLIPS lasted on average 6 days.  
 
*** TABLE 1 ABOUT HERE *** 
 
Diagnostic significance of BLIPS  
About two-thirds of BLIPS (68%, table 2) received a baseline ICD-10 diagnosis of 
ATPD. The vast majority of ATPD cases were characterized by schizophrenic 
symptoms: acute polymorphic psychotic disorder with symptoms of schizophrenia 
and acute schizophrenia-like psychotic disorder (44/54=78%). Conversely, acute 
polymorphic psychotic disorder without symptoms of schizophrenia accounted for 7% 
(4/54) of ATPD cases only. The second most frequent ICD-10 baseline psychotic 
diagnosis in subjects with BLIPS was unspecified nonorganic psychosis (15%), 
followed by mental and behavioural disorders due to use of cannabinoids (11%) and 
mania with psychotic symptoms (6%).  
 
*** TABLE 2 ABOUT HERE *** 
 
Prognostic significance of BLIPS  
The mean follow-up time was of 880.86 days (SD= 1038.44). Over follow-up, eight 
subjects (11%) had recurrent episodes of BLIPS, 5 subjects had 2 episodes and the 
remaining 3 experienced 3 episodes over a median period of 121 days. 
 
Risk of psychosis in BLIPS  
There were 28 conversions to psychosis (failures) over the follow-up time. The failure 
function (Figure 1) was: at 3 months 0.102 (95%CI 0.053-0.194), at 6 months 0.144 
(95%CI 0.082-0.244), at 12 months 0.189 (95%CI 0.117-0.301), at 24 months 0.303 
(95%CI 0.205-0.435), at 36 months 0.467 (95%CI 0.335-0.621), at 48 months 0.497 
(95%CI 0.360-0.652), at 60 months 0.543 (95%CI 0.394-0.701). The mean time to 
event was 2363 days (i.e. 6.47 years), SD 287, 95%CI 1802-295 (median 1788 days, 
i.e. 4.89 years).  
 
*** FIGURE 1 ABOUT HERE *** 
 
Univariate Cox regression analysis 
The univariate cox regression analysis revealed that seriously disorganizing or 
dangerous features (HR=3.637, 95%CI 1.680 – 7.874) and BLIPS recurrence (6 out of 
8 recurrent BLIPS developed psychosis, HR 3.989, 95%CI 1.589 – 10.011) increased 
significantly the risk of psychosis. The remaining factors being studied such as age, 
HoNOS, SOFAS, CAARMS P1-P4 total score, BLIPS duration, gender, borough, 
ethnicity, marital status, employment status and BLIPS subgroup were not significant 
(Table 3). 
 
*** TABLE 3 *** 
 
Multivariate cox regression analysis 
The final predictive model included only seriously disorganizing or dangerous 
features only (HR=4.391, 95%CI 1.370 - 14.078, Table 3). The failure function 
stratified for absence or presence of seriously disorganizing or dangerous BLIPS 
features (Figure 2) was respectively: at 3 months 0.056 (95%CI 0.019 - 0.165) and 
0.250 (95%CI 0.112 - 0.501), at 6 months 0.076 (95%CI 0.029 - 0.191) and 0.350 
(95%CI 0.185 - 0.597), at 12 months 0.124 (95%CI 0.057 - 0.257) and 0.401 (95%CI 
0.229 - 0.656), at 24 months 0.209 (95%CI 0.112 - 0.368) and 0.631 (95%CI 0.404 – 
0.853), at 36 months 0.312 (95%CI 0.174 - 0.521) and 0.778 (95%CI 0.547 – 0.943), 
at 48 months 0.369 (95%CI 0.212 - 0.590) and 0.778 (95%CI 0.547 – 0.943), at 60 
months 0.369 (95%CI 0.212 - 0.590) and 0.889 (95%CI 0.639 - 0.991). Visual 
inspection of model calibration plot (eFigure 1) shows good agreement between 
predicted and observed risk. 
  
*** FIGURE 2 ABOUT HERE *** 
 
Model robustness 
Bootstrapping confirmed that the multivariate cox regression equation based on 
seriously disorganizing or dangerous features was not overfit to the data: hazard ratio 
3.637 SE 1.44 Z=3.18 p<0.001, 95% CI 1.64 – 8.07, Wald 10.09, p=0.002.  
 
ROC analysis 
The ROC analysis indicated a sensitivity of 0.70, specificity of 0.78 for the presence 
of seriously disorganizing or dangerous features. The presence/absence of these 
features correctly classified 0.76 of cases developing psychosis with a likelihood 
positive ratio of 3.21 and a likelihood negative ratio of 0.38. The AUC was of 0.74 
(95% CI from 0.62 to 0.86).  
 
DISCUSSION   
To our knowledge this is the first original study of CAARMS-defined BLIPS ever 
conducted. Since it is based on a large sample and long-term follow-up, it makes clear 
advances from earlier observations in several ways. First, it enhances the 
understanding of the diagnostic significance of BLIPS by investigating their 
relationship with ICD-10 diagnoses. We found that most BLIPS met ICD-10 criteria 
for ATPD (68%) followed by unspecified nonorganic psychosis (15%), mental and 
behavioural disorders due to use of cannabinoids (11%) and mania with psychotic 
symptoms (6%). Second, it examines a number of clinical and sociodemographic 
factors and makes it possible to point out specific outcome predictors for BLIPS, 
while at the same time highlighting some conceptual limitations. We found that about 
one in two BLIPS subjects developed a psychotic disorder over time (5-year failure 
0.54). Recurrent BLIPS episodes were relatively infrequent (11%) but associated with 
higher risk of psychosis onset at the univariate analysis (HR=3.98). The best predictor 
of psychosis onset at the multivariate analysis was the presence of seriously 
disorganizing or dangerous features, which was associated with an extreme high risk 
(HR=4.39, 5-year failure 0.89) of transitioning to psychosis. 
 
The first aim of the current study was to address the diagnostic significance of the 
BLIPS compared to competing ICD-10 diagnoses. Our study’s findings suggest that 
about two-third of cases with BLIPS met the diagnostic criteria for ATPDs, further 
corroborating our recent meta-analytical findings of comparable risk of psychosis 
between BLIPS and ATPD constructs7. Conceptually, the BLIPS definition has more 
coherence with the acute and transient psychotic disorder construct as compared to 
other first-episode diagnoses. Because of this conceptual overlay, depending on the 
local availability of high risk services, young adults presenting with brief psychotic 
episodes may equally receive a diagnosis of established psychosis and start an 
antipsychotic treatment (as ATPD/BPD), or an at-risk diagnosis (as BLIPS/BIPS) and 
undergo psychological interventions27. To overcome these inconsistencies these 
categories should be further compared, rather than abandoned28. Comparative 
analyses may specifically benefit the UHR research, because there is more knowledge 
into the epidemiology, course and outcomes of ATPD (e.g. large follow-up studies 
with up to 5426 subjects29) than in the BLIPS construct (only the current study 
available). For example, it was argued that the BLIPS is diagnostically pluripotent 
and that it is not specific for schizophrenia spectrum psychoses. However, the meta-
analytical risk of developing affective psychoses is actually higher in ATPD than in 
BLIPS (eFigure 4 from9). Thus, there is more evidence for pluripotential outcomes in 
ATPD than in BLIPS, with up to one third of initial ATPD cases transitioning to 
affective psychoses30. In fact, we found that BLIPS tend to overlap with the ATPD 
subtypes characterized by schizophrenic symptoms: acute polymorphic psychotic 
disorder with symptoms of schizophrenia (F23.1) and acute schizophrenia-like 
psychotic disorder (F23.2). This is probably because BLIPS encompass Schneider’s 
first-rank symptoms, which have been incorporated into the ICD-10 criteria for 
schizophrenia. Conversely, ATPD constitutes a heterogeneous category including 
subtypes with polymorphic, schizophrenic and prevalently delusional symptoms, 
which are likely to herald longer lasting psychotic and affective disorders28. While 
acute polymorphic psychotic disorder lasts less than 3 months and refers to the earlier 
concepts of bouffée délirante and cycloid psychosis, featuring varied delusions, 
hallucinations, perceptual changes, perplexity and emotional turmoil shifting daily or 
even faster, the ATPD subtypes with schizophrenic symptoms are set apart from 
schizophrenia only by temporal criteria of less than 1 month. The available evidence 
suggests that these subtypes have a high risk to evolve into schizophrenia over the 
short and longer terms29. The overlap between BLIPS and ATPD schizophrenic 
subtypes is also consistent with meta-analytical evidence indicating the UHR state 
specifically predicts schizophrenia spectrum psychoses (73% of transitions) rather 
than affective psychotic outcomes (11% of transitions only)31. Recent original studies 
in UHR subjects (n=271) as compared to comparison subjects (n=171) further 
confirmed no evidence of diagnostic pluripotentiality with respect to incident anxiety, 
bipolar, or non-bipolar mood disorders32. 
 
The second aim of the current study was to address the prognostic significance of the 
BLIPS under the CAARMS framework and to address the impact of 
sociodemographic and clinical predictors of psychosis onset. The overall risk of 
psychosis in the long term (5-year) was 0.54 and it is in line with recent meta-
analytical estimates in brief psychotic episodes7. This value is also very similar to the 
0.56 meta-analytical proportion of diagnostic instability observed from an initial 
ATPD33. The univariate analysis revealed that recurrent BLIPS, although not 
frequent, had a fourfold increase in this risk (HR=3.89) compared to mono-episodic 
BLIPS. Recurrent BLIPS may have a significant prognostic relevance because 
repeated episodes of BLIPS would not qualify as transition to psychosis under the 
CAARMS 12/2006 but rather still as UHR state. However, we found that the vast 
majority (6/8) of subjects presenting with recurrent BLIPS eventually developed a 
psychotic disorder (lasting more than 7 days). As the two subjects who did not 
develop psychosis had used cannabis during their index episode, it is possible to 
speculate that recurrent BLIPS not associated with drug abuse may almost inevitably 
transit to psychosis. This result, if validated by future studies, would question the 
clinical utility of a 7-day observation window for recurrent BLIPS, advocating more 
assertive monitoring and focused treatments.   
However, BLIPS recurrence did not survive the multivariate analysis, which selected 
only the presence of seriously disorganizing or dangerous BLIPS features as core 
predictive factor for BLIPS outcomes, with a fourfold increase in risk (HR=4.39). It is 
possible to hypothesize that the SIPS/SOPS authors had introduced this exclusion 
criterion on the assumption that this BLIPS subgroup would present with symptoms 
and behaviour that were too extreme to qualify for a state of risk. Such an assumption 
remained untested for about two decades, until our bootstrapping analysis confirmed 
the robustness of their poor prognostic significance in the CAARMS framework. The 
BLIPS without seriously disorganizing or dangerous features showed a 5-year 0.37 
risk of developing psychosis, as compared with the 5-year 0.89 for the seriously 
disorganizing or dangerous BLIPS. This was also reflected by an acceptable test 
performance as observed with the AUC. The high transition risk in seriously 
disorganizing or dangerous BLIPS may truly reflect the presence of extreme state 
factors that are close to the psychosis threshold34, as hypothesized by the SIPS/SOPS 
authors (see clinical implications below). They may have elaborated the seriously 
disorganizing or dangerous exclusion criterion on the basis of their earlier work on 
psychopathological subtypes of schizophrenia indicating that a drift toward 
disorganization (hebephrenia, see eDiscusson for details) was associated with 
“deterioration" and poorer functional outcome35.  
 
Implications for clinical practice and research  
There may be some implications for clinical practice and research. The current 
findings contribute to the recent accumulating evidence pointing to the BLIPS 
distinctiveness as compared to the other UHR subgroups. Our results indicate that 
BLIPS represent natural fluctuations of psychosis in individuals with psychotic 
disorder4. Furthermore, it has been argued that the 7-day duration proposed for the 
BLIPS would be a “clinically meaningful point” (page 134)36 to initiate antipsychotic 
treatments for UHR subjects, in order to minimize overtreatment of false positives. 
However, no studies show that a 7-day cutoff is effective in doing so. In clinical 
practice, the introduction of BLIPS has not completely prevented antipsychotic 
treatments of UHR subjects. The findings of our recent meta-analysis revealed that 
about 30% of BLIPS (or BIPS) subjects did receive antipsychotic treatments as 
routine clinical practice of high risk services in the past two decades6. More to point, 
the BLIPS construct is not strictly necessary to promote a delayed introduction of 
antipsychotic medication in favor of potentially safer interventions. In fact, 
comprehensive psychosocial interventions are already under development for patients 
receiving a standard diagnosis of first-episode psychosis37. Furthermore, the 7-day 
cutoff and current UHR treatments are based on the assumption that the UHR group is 
homogeneous. Conversely, our meta-analysis indicated that there is a differential 
level of risk of developing psychosis across different UHR subgroups 
(BLIPS>APS>GRD)6. This suggests that there may be different clinically meaningful 
points for initiating treatments across BLIPS, APS, GRD subgroups or even within 
the same subgroup. Stratified interventions targeting the differential level of risk for 
psychosis in UHR subgroups should be specifically considered by updated 
international guidelines. Another publication in the current special issue is presenting 
a pilot attempt to integrate these findings into a developmental clinical staging model 
that is based on hierarchical symptom severity. In this model, BLIPS cases represent 
the most severe clinical stage preceding the psychosis onset.  
Another implication relates to the clinical significance of disorganizing or dangerous 
features. Whether these features are predictors of psychosis onset from an at risk state 
or early markers of recurrent psychotic disorders already present at baseline clearly 
depends on the variable psychosis threshold4 adopted by the CAARMS vs the SIPS. 
Indeed, disorganizing or dangerous features generate substantial diagnostic 
disagreement across the two instruments (for a full discussion see our previous 
comparative CAARMS vs SIPS analysis10). It is well known that the point at which 
an individual crosses the line from high risk or UHR state to psychosis threshold is 
arbitrary38. However, the historical association of disorganized symptoms with poor 
outcomes, reviewed in the eDiscussion, and the fact that these features yielded an 
extreme risk of psychosis in CAARMS-defined BLIPS individuals who were already 
meeting criteria for ATPD may suggest that these individuals have already passed the 
psychosis threshold at baseline. Unfortunately this finding is of limited psychometric 
utility in the field, because disorganizing or dangerous features are not 
operationalized in the available UHR instruments and therefore likely to be affected 
by assessment biases (see other limitations in the eLimitations). 
 
CONCLUSIONS 
About half of cases with BLIPS developed a frank psychosis in the long-term. BLIPS 
were most likely to meet the criteria for ICD-10 diagnosis of ATPD at intake, mainly 
the subtypes with schizophrenic symptoms. Recurrent BLIPS were relatively 
infrequent but tended to transit to psychosis. Seriously disorganizing or dangerous 
features were associated with an extreme risk of psychosis.  
 
REFERENCES: 
1. Fusar-Poli P, Borgwardt S, Bechdolf A, et al. The Psychosis High-Risk State A 
Comprehensive State-of-the-Art Review. JAMA Psychiatry Jan 2013;70(1):107-120. 
2. Yung A, Yuen H, McGorry P, et al. Mapping the onset of psychosis: the 
Comprehensive Assessment of At-Risk Mental States. ANZJP 2005;39(11-12):964-
971. 
3. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring 
and care of young people at incipient risk of psychosis. Schizophrenia bulletin 
1996;22(2):283-303. 
4. Fusar-Poli P, Van Os J. Lost in transition: setting psychosis trehsold in prodromal 
research. Acta psychiatrica Scandinavica 2013;127 (3):248-252. 
5. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured 
interview for prodromal syndromes and the scale of prodromal symptoms: 
predictive validity, interrater reliability, and training to reliability. Schizophrenia 
bulletin 2003;29(4):703-715. 
6. Fusar-Poli P, Cappucciati M, Borgwardt S, et al. Heterogeneity of risk for psychosis 
within subjects at clinical high risk: meta-analytical stratification JAMA Psychiatry 
2016;73(2):113-120. 
7. Fusar-Poli P, Cappucciati M, Bonoldi I, et al. Prognosis of brief psychotic episodes: a 
meta-analysis. JAMA Psychiatry 2016;73(3):211-220. 
8. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured 
interview for prodromal syndromes and the scale of prodromal symptoms: 
predictive validity, interrater reliability, and training to reliability. Schizophrenia 
bulletin 2003;29(4):703-715. 
9. Fusar-Poli P, Cappucciati M, Bonoldi I, et al. Prognosis of Brief Psychotic Episodes: A 
Meta-analysis. JAMA psychiatry Jan 13 2016:1-10. 
10. Fusar-Poli P, Cappucciati M, Rutigliano G, et al. Towards a Standard Psychometric 
Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus 
SIPS. Psychiatry J 2016;2016:7146341. 
11. Fusar-Poli P, Byrne M, Badger S, Valmaggia LR, McGuire PK. Outreach and support in 
south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for 
young individuals at high clinical risk for psychosis. Eur Psychiatry Jun 
2013;28(5):315-326. 
12. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Comprehensive Assessment of at Risk 
Mental State. Melbourne; 2006. 
13. Fusar-Poli P, Frascarelli M, Valmaggia L, et al. Antidepressant, antipsychotic and 
psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-
year naturalistic study. Psychological medicine Apr 2015;45(6):1327-1339. 
14. McGlashan TH, Walsh B, Wood SJ. The Psychosis-Risk Syndrome. Handbook for 
Diagnosis and Follow-up. New York: Oxford University Press; 2010. 
15. Orrell M, Yard P, Handysides J, Schapira R. Validity and reliability of the Health of the 
Nation Outcome Scales in psychiatric patients in the community. The British journal 
of psychiatry : the journal of mental science May 1999;174:409-412. 
16. American Psychiatric Association. Diagnostic and statistical manual of mental 
disorders. 3rd ed.; 3rd ed., rev.; 4th ed.; 4th ed., text. rev. Washington, DC: 
American Psychiatric Association 1980, 1987, 1994, 2000. 
17. Stewart R, Soremekun M, Perera G, et al. The South London and Maudsley NHS 
Foundation Trust Biomedical Research Centre (SLAM BRC) case register: 
development and descriptive data. BMC psychiatry 2009;9:51. 
18. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Amer 
Statist Assn 1958;53(282):457-481. 
19. Greenwood M. The natural duration of cancer. London 1926. 
20. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on 
weighted residuals. Biometrika 1994;81:515-526. 
21. Cornblatt B, Carrión R, Auther A, McLaughlin D, Olsen R, John M, Correll C. Psychosis 
Prevention: A Modified Clinical High Risk Perspective From the Recognition and 
Prevention (RAP) Program. The American journal of psychiatry 2015. 
22. Hosmer D, Lemeshow S. Applied Logistic Regression. 2nd ed. ed. New York: Wiley; 
2000. 
23. Akaike H. Likelihood of a model and information criteria. J Econom 1981;16:3-14. 
24. Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: 
application to the Cox regression model. Statistics in medicine Dec 
1992;11(16):2093-2109. 
25. Obuchowski NA, Lieber ML, Wians FH, Jr. ROC curves in clinical chemistry: uses, 
misuses, and possible solutions. Clinical chemistry Jul 2004;50(7):1118-1125. 
26. Hosmer W, Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to 
Event Data. New York, NY: Wiley & Sons; 1999. 
27. Fusar-Poli P, Yung AR, McGorry P, van Os J. Lessons learned from the psychosis high-
risk state: towards a general staging model of prodromal intervention. Psychological 
medicine Jan 2014;44(1):17-24. 
28. Queirazza F, Semple DM, Lawrie SM. Transition to schizophrenia in acute and 
transient psychotic disorders. The British journal of psychiatry : the journal of mental 
science 2014;204:299-305. 
29. Castagnini A, Foldager L. Epidemiology, course and outcome of acute polymorphic 
psychotic disorder: implications for ICD-11. Psychopathology 2014;47(3):202-206. 
30. Castagnini AC, Munk-Jorgensen P, Bertelsen A. Short-term course and outcome of 
acute and transient psychotic disorders: Differences from other types of psychosis 
with acute onset. The International journal of social psychiatry Feb 2016;62(1):51-
56. 
31. Fusar-Poli P, Bechdolf A, Taylor MJ, Bonoldi I, Carpenter WT, Yung AR, McGuire P. At 
risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic 
outcomes in individuals at high clinical risk. Schizophrenia bulletin Jul 
2013;39(4):923-932. 
32. Webb JR, Addington J, Perkins DO, et al. Specificity of Incident Diagnostic Outcomes 
in Patients at Clinical High Risk for Psychosis. Schizophrenia bulletin Sep 
2015;41(5):1066-1075. 
33. Fusar-Poli P, Cappucciati M, Rutigliano G, et al. Diagnostic Stability of ICD/DSM First 
Episode Psychosis Diagnoses: Meta-analysis. Schizophrenia bulletin Mar 15 2016. 
34. Cornblatt BA, Carrion RE. Deconstructing the Psychosis Risk Syndrome: Moving the 
Field of Prevention Forward. JAMA Psychiatry Dec 30 2015:1-2. 
35. McGlashan TH, Fenton WS. Subtype progression and pathophysiologic deterioration 
in early schizophrenia. Schizophrenia bulletin 1993;19(1):71-84. 
36. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-
risk group: psychopathology and clinical features. Schizophrenia research Apr 1 
2004;67(2-3):131-142. 
37. Francey SM, Nelson B, Thompson A, et al. Who needs antipsychotic medication in 
the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology 
and ethics in the era of early intervention. Schizophrenia research Jun 2010;119(1-
3):1-10. 
38. Yung AR, Nelson B, Thompson A, Wood SJ. The psychosis threshold in Ultra High Risk 
(prodromal) research: is it valid? Schizophrenia research Jul 2010;120(1-3):1-6. 
39. World Health Organization. International classification of diseases, tenth revision 
(ICD-10). Geneva: WHO, 1990 1990. 
Table 1. Clinical and sociodemographic characteristics of subjects with 
BLIPS detected by the OASIS service (n=80). 
  
N Mean SD 
Age (years)  80 25.06 5.45 
Baseline SOFAS 
 
70 57.93 14.14 
H0NOS (adjusted total) 45 9.91 7.26 
CAARMS P1-P4 total score (a) 80 50.93 17.49 
BLIPS duration (days) 80 6.17 1.13 
  
   
  N Count  % 
Gender 
 
80 
  
 
Females 
 
33 41.30 
 
Males 
 
47 58.80 
Borough 
 
77 
  
 
Lambeth 
 
41 53.25 
 
Southwark 
 
26 33.78 
 
Other 
 
10 12.97 
Ethnicity 
 
80 
  
 
White 
 
38 47.50 
 
Black  
 
36 45.00 
 
Other 
 
6 7.50 
Marital status 
 
76 
  
 
Married 
 
4 5.26 
 
Separated or divorced 
 
3 3.95 
 
Single 
 
55 72.37 
 
In a relationship 
 
14 18.42 
Employment status 
 
77 
  
 
Employed 
 
25 32.47 
 
Student 
 
21 27.27 
 
Unemployed 
 
31 40.26 
BLIPS subgroup 
 
80 
  
 
BLIPS only 
 
49 61.30 
 
BLIPS+APS 
 
26 32.50 
 
BLIPS+GRD 
 
1 1.30 
 
BLIPS+APS+GRD 
 
4 5.00 
BLIPS seriously disorganizing or dangerous 75 
  
 
No 
 
55 73.33 
 
Yes 
 
20 26.67 
BLIPS recurrence 
 
76 
  
 
Single episode 
 
68 89.47 
 Recurrent episodes (b)   8 10.53 
(a) Computed as P1 severity * P1 frequency + P2 severity * P2 frequency 
+ P3 severity * P3 frequency + P4 severity * P4 frequency; (a) five 
subjects had 2 episodes and 3 subjects had 3 episodes, time to BLIPS 
recurrence, mean 267.13 days, 95% CI 0 - 591.89, median 121 days, 
range 32 - 1203. 
 Table 2. ICD-10 baseline diagnoses for BLIPS in subjects presenting with BLIPS  
to the OASIS service (n=80). Diagnostic subtypes in italics fall under the umbrella 
of the main diagnostic categories. 
ICD-10 
code39 
N % 
          
Acute and transient psychotic disorder F23 54 68 
  
   
 
Acute polymorphic psychotic disorder without symptoms of schizophrenia F23.0 4 5 
 
Acute polymorphic psychotic disorder with symptoms of schizophrenia F23.1 22 28 
 
Acute schizophrenia-like psychotic disorder F23.2 20 25 
 
Other acute and transient psychotic disorders F23.8 7 9 
 
Acute and transient psychotic disorder, unspecified F23.9 1 1 
  
   
Unspecified nonorganic psychosis F29 12 15 
  
   
Mental and behavioural disorders due to use of cannabinoids F12 9 11 
  
   
 
Acute intoxication F12.0 8 10 
 
Dependence syndrome F12.2 1 1 
  
   
Manic episode F30 5 6 
  
   
 
Mania with psychotic symptoms F30.2 5 6 
         
     
 Table 3. Clinical and sociodemographic factors predicting the onset of psychosis in BLIPS (n=80). Cox regression analyses. 
  
Log 
Likelihood X2 
Sig B SE 
Hazard 
Ratio 
95% CI Wald  P 
Univariate analysis                   
Age (years) 0.984 0.321 0.034 0.035 1.035 0.967 1.108 0.977 0.323 
HONOS  2.721 0.099 0.049 0.030 1.051 0.990 1.115 2.653 0.103 
SOFAS 0.242 0.623 0.008 0.016 1.008 0.977 1.039 0.242 0.623 
CAARMS P1-P4 total score 1.030 0.310 0.012 0.012 1.012 0.989 1.036 1.028 0.311 
BLIPS duration (days) 1.803 0.179 0.053 0.039 1.054 0.976 1.139 1.781 0.182 
Gender (a) 0.317 0.574 -0.217 0.386 0.805 0.377 1.716 0.316 0.574 
Borough (b) 1.056 0.590 0.115 0.474 1.122 0.443 2.843 0.059 0.808 
Ethnicity (c) 0.326 0.850 0.170 0.393 1.185 0.549 2.559 0.186 0.666 
Marital status (d) 0.830 0.842 0.323 0.621 1.381 0.409 4.665 0.270 0.603 
Employment status (e) 0.199 0.905 -0.182 0.458 0.833 0.340 2.044 0.158 0.691 
BLIPS subgroup (f) 0.699 0.873 0.186 0.393 1.205 0.558 2.601 0.226 0.635 
BLIPS seriously disorganizing or dangerous (g) 12.305 <0.001 1.291 0.394 3.637 1.680 7.874 10.740 0.001 
BLIPS recurrence (h) 10.116 0.001 1.383 0.470 3.989 1.589 10.011 8.681 0.003 
Multivariate analysis (i)                   
BLIPS seriously disorganizing or dangerous (g) 7.368 0.007 1.480 0.594 4.391 1.370 14.078 6.196 0.013 
a)  females vs males, b)  Southwark vs Lambeth, c) black vs white, d) single vs in a relationship, e) employed vs unemployed, f)  BLIPS+APS 
vs BLIPS only, g) seriously disorganizing and dangerous vs not seriously disorganizing and dangerous,  h) recurrent vs not recurrent i) 
factors selected from univariate analysis: HONOS, BLIPS duration, BLIPS seriously disorganizing or dangerous, BLIPS recurrence. 
Figure 1. Kaplan-Meier failure function (risk of psychosis onset) in BLIPS subjects 
(n=80). The last transition to psychosis was observed at 1788 days since initial 
assessment. 
 
 
 
Figure 2. Kaplan-Meier failure function (risk of psychosis onset) in BLIPS subjects 
(n=80) stratified for the presence of seriously disorganizing or dangerous features. 
Log-rank X2=12.31, P=0.001. 
 
 
 
